Home

Hearings from Recent Congresses

111th Congress

Hearing on “U.S. Counternarcotics Strategy in Afghanistan”
Wednesday, October 21, 2009
11:00 a.m.
138 Dirksen Senate Office Building

Senator Feinstein's statement | Senator Grassley's statement

Witnesses:
Michael A. Braun (Bio | Testimony | Addendum)
Managing Partner, Spectre Group International, LLC;
Former Chief of Operations for the Drug Enforcement Administration

Vanda Felbab-Brown (Bio | Testimony)
Foreign Policy Fellow
21st Century Defense Initiative
Brookings Institute

Norine MacDonald (Bio | Testimony)
President and Founder
The International Council on Security and Development

Law Enforcement Responses to Mexican Drug Cartels
Senate Judiciary Committee
Subcommittee on Crime and Drugs
DATE: March 17, 2009
TIME: 10:30 AM
ROOM: Dirksen-226

108th Congress

The Abuse of Anabolic Steroids and Their Precursors by Adolescent and Amateur Athletes
Caucus on International Narcotics Control
Scheduled for:
Tuesday, July 13, 2004 - 10:00 AM
Dirksen Senate Office Building room 215

Money Laundering: Current Status of Our Efforts To Coordinate and Combat Money Laundering and Terrorist Financing
Caucus on International Narcotics Control
March 4, 2004

Regarding U.S. Narcotics Policy in Colombia
Caucus on International Narcotics Control
June 3, 2003

107th Congress

The Transit Zone: Strategy and Balance
Caucus on International Narcotics Control
May 15, 2001

America at Risk: The Ecstasy Threat
Caucus on International Narcotics Control
March 21, 2001

Plan Colombia: An Initial Assessment 
Caucus on International Narcotics Control
February 28, 2001

106th Congress

Ecstasy: Underestimating the Threat
Caucus on International Narcotics Control
July 25, 2000

The Domestic Consequences of Heroin Use
Caucus on International Narcotics Control
May 9, 2000